Suppr超能文献

高变区在链球菌M蛋白中的作用:一种人类补体抑制剂的结合

Role of the hypervariable region in streptococcal M proteins: binding of a human complement inhibitor.

作者信息

Johnsson E, Berggård K, Kotarsky H, Hellwage J, Zipfel P F, Sjöbring U, Lindahl G

机构信息

Department of Medical Microbiology, Lund University, Sweden.

出版信息

J Immunol. 1998 Nov 1;161(9):4894-901.

PMID:9794423
Abstract

Antigenic variation allows pathogenic microorganisms to evade the immune system of the infected host. The variable structure must play an important role in pathogenesis, but its function is in most cases unknown. Here, we identify a function for the surface-exposed hypervariable region of streptococcal M5 protein, a virulence factor that inhibits phagocytosis. The hypervariable region of M5 was found to bind the human complement inhibitor FHL-1 (factor H-like protein 1), a 42-kDa plasma protein. Plasma absorption experiments with M5-expressing bacteria showed that the interaction with FHL-1 occurs also under physiologic conditions. Studies of another extensively characterized M protein, M6, indicated that this protein also has a binding site for FHL-1 in the hypervariable region. The complement-inhibitory function of FHL-1 was retained after binding to streptococci, suggesting that bound FHL-1 protects bacteria against complement attack. All available data now indicate that FHL-1, or another human complement inhibitor, binds to the hypervariable region of M proteins. These findings provide insights into the forces that drive antigenic variation and may explain why the hypervariable region of M protein is essential for phagocytosis resistance. Moreover, these data add to a growing body of evidence that human complement inhibitors are major targets for pathogenic microorganisms.

摘要

抗原变异使致病微生物能够逃避被感染宿主的免疫系统。这种可变结构在发病机制中必定起着重要作用,但其功能在大多数情况下尚不清楚。在此,我们确定了链球菌M5蛋白表面暴露的高变区的一种功能,M5蛋白是一种抑制吞噬作用的毒力因子。研究发现,M5的高变区能结合人补体抑制剂FHL-1(类因子H蛋白1),一种42 kDa的血浆蛋白。用表达M5的细菌进行的血浆吸收实验表明,在生理条件下也会发生与FHL-1的相互作用。对另一种已被广泛研究的M蛋白M6的研究表明,该蛋白在高变区也有一个FHL-1结合位点。FHL-1与链球菌结合后仍保留其补体抑制功能,这表明结合的FHL-1可保护细菌免受补体攻击。目前所有可得数据均表明,FHL-1或另一种人补体抑制剂会与M蛋白的高变区结合。这些发现为驱动抗原变异的因素提供了见解,并可能解释为什么M蛋白的高变区对于抗吞噬作用至关重要。此外,这些数据进一步证明了越来越多的证据表明人补体抑制剂是致病微生物的主要靶标。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验